3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Myelodysplastic Syndromes
13
Anemia, Refractory, with Excess of Blasts
11
Myeloproliferative Disorders
9
Leukemia, Myeloid, Acute
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Hematologic Neoplasms
8
Lymphoma, Non-Hodgkin
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Anemia, Aplastic
7
Anemia
7
Lymphoma
6
Leukemia, Myelomonocytic, Chronic
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Multiple Myeloma
5
Leukemia
5
Hodgkin Disease
5
Venous Thromboembolism
4
Primary Myelofibrosis
4
Lymphoma, Mantle-Cell
4
Lymphoma, Follicular
4
Waldenstrom Macroglobulinemia
3
Primary Immunodeficiency Diseases
3
Neoplasms, Plasma Cell
3
Neoplasms
3
Lymphoma, B-Cell, Marginal Zone
3
Burkitt Lymphoma
3
Bone Marrow Failure Disorders
3
Thrombocythemia, Essential
2
Sezary Syndrome
2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Embolism
×
Classical hematology
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled